|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-6-5
|
|
pubmed:abstractText |
The prognosis of lung cancer is still poor, since there are few early detection tools available yet. So, it is important to identify more efficient and clinically applicable biomarkers associated with the prognosis in as earlier stages as possible.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
46-53
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17350713-Adenocarcinoma,
pubmed-meshheading:17350713-Aged,
pubmed-meshheading:17350713-Antigens, CD,
pubmed-meshheading:17350713-Antigens, CD63,
pubmed-meshheading:17350713-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17350713-Carcinoma, Squamous Cell,
pubmed-meshheading:17350713-Cell Line, Tumor,
pubmed-meshheading:17350713-Female,
pubmed-meshheading:17350713-Humans,
pubmed-meshheading:17350713-Immunohistochemistry,
pubmed-meshheading:17350713-Lung Neoplasms,
pubmed-meshheading:17350713-Male,
pubmed-meshheading:17350713-Microarray Analysis,
pubmed-meshheading:17350713-Middle Aged,
pubmed-meshheading:17350713-Neoplasm Staging,
pubmed-meshheading:17350713-Platelet Membrane Glycoproteins,
pubmed-meshheading:17350713-Prognosis,
pubmed-meshheading:17350713-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:17350713-Survival Analysis,
pubmed-meshheading:17350713-Tumor Burden,
pubmed-meshheading:17350713-Tumor Markers, Biological
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
|
|
pubmed:affiliation |
Department of Pathology, Dankook University College of Medicine, Chungnam 330-714, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
